Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Asset Utilization Ratio (2025 - 2026)

Updated

Global Innovative Platforms' Asset Utilization Ratio was 0.33 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 1.0% from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn 0.62
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn 0.49
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn 0.47
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 0.52
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn 0.46
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 0.51
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn 0.40
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn 0.58
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn 0.31
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - 0.33
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.33
Mar 31, 2026 0.33
Dec 31, 2025 0.14
API Access

Global Innovative Platforms Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=GIPL&period=max&api_key=YOUR_API_KEY